Within this concentration range, DGLA appeared to induce apoptosis in ovarian cancer cells as shown by an increase in PARP and caspase 3 cleavage and upregulated DR5 expression, which helps to explain mechanism of reporter DGLA anticancer activity in multiple cancers. This evidence concerns the gene CASP3 and ovarian carcinoma.